Free Trial

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

Quest Diagnostics logo
$160.48 -0.68 (-0.42%)
(As of 01:05 PM ET)

Quest Diagnostics Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 6Estimated
Actual EPS
(Oct. 22)
$2.30 Beat By $0.04
Consensus EPS
(Oct. 22)
$2.26

Quest Diagnostics posted Q3 2024 earnings on October 22, 2024, reporting an EPS of $2.30, which topped the consensus estimate of $2.26 by $0.04. Quarterly revenue rose 8.5% year-over-year to $2.49 billion, above analysts' expectations of $2.43 billion. With a trailing EPS of $7.44 and a P/E Ratio of 21.61, Quest Diagnostics' earnings are expected to grow 8.99% next year, from $8.90 to $9.70 per share.

DGX Upcoming Earnings

Quest Diagnostics' next earnings date is estimated for Thursday, February 6, 2025, based off prior year's reporting schedules.

Get Quest Diagnostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.84$2.17$1.96 
Q2 20243$2.29$2.32$2.30 
Q3 20243$2.26$2.32$2.29 
Q4 20243$2.19$2.20$2.20 
FY 202412$8.58$9.01$8.75 
Q1 20253$2.17$2.24$2.20 
Q2 20253$2.43$2.59$2.51 
Q3 20253$2.48$2.50$2.49 
Q4 20253$2.38$2.62$2.50 
FY 202512$9.46$9.95$9.70 
Q1 20261$2.60$2.60$2.60 
Q2 20261$2.62$2.62$2.62 
Q3 20261$2.61$2.61$2.61 

Quest Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/6/2025
(Estimated)
------- 
10/22/2024Q3 2024$2.26$2.30+$0.04$2.61$2.43B$2.49B      
7/23/2024Q2 2024$2.31$2.35+$0.04$2.67$2.39B$2.40B        
4/23/2024Q1 2024$1.86$2.04+$0.18$2.36$2.29B$2.37B        
2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25B$2.29B        
10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27B$2.30B        
7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25B$2.34B      
4/27/2023Q1 2023$1.97$2.04+$0.07$2.30$2.20B$2.33B      
2/2/2023Q4 2022$1.90$1.98+$0.08$3.09$2.26B$2.33B      

Quest Diagnostics Earnings - Frequently Asked Questions

Quest Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates. Learn more on DGX's earnings history.

Quest Diagnostics updated its FY24 earnings guidance on Tuesday, October, 22nd. The company provided earnings per share (EPS) guidance of $8.85-$8.95 for the period, compared to the consensus EPS estimate of $8.89. The company issued revenue guidance of $9.80-$9.85 billion, compared to the consensus revenue estimate of $9.68 billion.

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.30 earnings per share (EPS) to beat the analysts' consensus estimate of $2.26 by $0.04. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

The conference call for Quest Diagnostics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Quest Diagnostics's latest earnings report can be read online.
Read Transcript

Quest Diagnostics's earnings report can be found in their filing with the SEC.
View SEC filing

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.25 billion.

Quest Diagnostics (NYSE:DGX) has a recorded net income of $854 million. DGX has generated $7.44 earnings per share over the last four quarters.

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 21.61 and a forward price-to-earnings ratio of 18.07. The price/earnings-to-growth ratio is 2.77.

Quest Diagnostics's earnings are expected to grow from $8.90 per share to $9.70 per share in the next year, which is a 8.99% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:DGX) was last updated on 11/20/2024 by MarketBeat.com Staff
From Our Partners